Categories
Lupin Limited — Updates, 05-05-2026: Press Release
05-05-2026 · 09:11 am
Lupin received U.S. FDA approval for Glycerol Phenylbutyrate Oral Liquid, a drug for urea cycle disorders. The reference product had annual sales of $337 million, highlighting a strong market opportunity.
No comments yet. Be the first to comment!